IMU Biosciences

About:

IMU is a discovery engine mapping the immune system to advance precision medicine.

Website: https://www.imubiosciences.com

Top Investors: Molten Ventures, Life Extension Ventures, Beaumont Capital

Description:

IMU is a discovery engine mapping the immune system to advance precision medicine.

Total Funding Amount:

11.5M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2021-01-01

Founders:

Adam Laing, Mario Cantero, Tom Hayday

Number of Employees:

11-50

Last Funding Date:

2024-01-24

IPO Status:

Private

Industries: